Humedix Co. Ltd. | Ownership
Companies that own Humedix Co. Ltd.
BlackRock Fund Advisors
137,191
1.47%
0
0%
09/05/2018
Norges Bank Investment Management
136,882
1.46%
88,253
0%
12/31/2017
The Vanguard Group, Inc.
121,182
1.29%
91
0%
07/31/2018
Dimensional Fund Advisors LP
88,916
0.95%
4,669
0%
04/30/2018
BlackRock Advisors (UK) Ltd.
15,828
0.17%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
10,830
0.12%
2,848
0%
04/30/2018
Charles Schwab Investment Management, Inc.
3,668
0.04%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
3,307
0.04%
0
0%
03/31/2018
State Street Global Advisors Ltd.
1,440
0.02%
0
0%
09/05/2018
SSgA Funds Management, Inc.
1,372
0.02%
0
0%
09/06/2018
| Address |
Unit 603, Anyang Mega Valley
Anyang GY 14056
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.humedix.com |
| Updated |
09/14/2018 |
| Humedix Co., Ltd. is a holding company, which engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang, South Korea. |
